185 related articles for article (PubMed ID: 10931130)
1. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26.
Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H
Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130
[TBL] [Abstract][Full Text] [Related]
2. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients.
Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I
Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
[TBL] [Abstract][Full Text] [Related]
4. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age.
Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH
Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.
Ulusoy H; Kamanli A; Ilhan N; Kuru O; Arslan S; Alkan G; Ozgocmen S
Rheumatol Int; 2012 Dec; 32(12):3857-62. PubMed ID: 22193227
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD30 in pediatric patients with atopic dermatitis.
Frezzolini A; Paradisi M; Ruffelli M; Cadoni S; De Pità O
Allergy; 1997 Jan; 52(1):106-9. PubMed ID: 9062638
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous CD30+ cells in children with atopic dermatitis.
Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Stone SF; French MA
Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
[TBL] [Abstract][Full Text] [Related]
10. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis.
Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A
Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807
[TBL] [Abstract][Full Text] [Related]
11. Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune Thrombocytopenia.
Wang H; Gu X; Li H; Yin L; Tao W; Yu J; Zhou Q; Mu H; Shen Y; Yao J; Liu L; Bi H; Yang R; Zhou Z
Biomed Res Int; 2020; 2020():1279371. PubMed ID: 32337220
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble CD30 in patients with atopic dermatitis: correlations with age, disease duration and severity.
El Mongy S; Metwaly SS; Arafat MS; Hady HA
Egypt J Immunol; 2008; 15(1):123-9. PubMed ID: 20306677
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention.
Bottari V; Frezzolini A; Ruffelli M; Puddu P; Fontana L; De Pità O
Allergy; 1999 May; 54(5):507-10. PubMed ID: 10380784
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis.
Dummer W; Bröcker EB; Bastian BC
Br J Dermatol; 1997 Aug; 137(2):185-7. PubMed ID: 9292064
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.
Fölster-Holst R; Henseler T; Wehde J; Lemke H; Weichenthal M; Christophers E; Hansen HP
Acta Derm Venereol; 2002; 82(4):245-8. PubMed ID: 12361126
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1/Th2 balance?
Hoshimoto K; Ohta N; Ohkura T; Inaba N
Gynecol Obstet Invest; 2000; 50(4):260-3. PubMed ID: 11093050
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble CD26 and CD30 in patients on hemodialysis.
Nakao K; Nagake Y; Okamoto A; Ichikawa H; Yamamura M; Makino H
Nephron; 2002 Jun; 91(2):215-21. PubMed ID: 12053056
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD30 and cyclosporine in severe atopic dermatitis.
Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
